• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Half-dose antenatal betamethasone is inferior to full dose for preventing usage of neonatal surfactant

byJessie WillisandTeddy Guo
August 31, 2022
in Obstetrics, Pediatrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Half-dose antenatal betamethasone did not meet the noninferiority criteria when compared to full dose at preventing the primary outcome of neonatal surfactant usage.

2. There were no differences in neonatal death and adverse events between the half-dose and full dose groups.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Antenatal betamethasone is standardly given prior to preterm delivery to accelerate fetal lung maturation. The typical dosage is given twice 24 hours apart. However, recent studies suggest that this dosage may have dose-related side effects. This study, BETADOSE, was a non-inferiority trial that assessed the impact of half-dose betamethasone compared to standard dose on the need for intratracheal surfactant within 48 hours of birth. Based on a predefined cut-off, the use of half-dose was unable to show noninferiority compared to full dose betamethasone. There were no differences seen in neonatal death and severe adverse events between the two groups. Limitations of this study include having surfactant usage as a proxy for neonatal respiratory outcomes, as this could differ between clinicians. Additionally, this study is unable to assess the long-term neonatal effects of half-dose antenatal steroids compared to standard dosage. Nevertheless, the results of this study do not support the reduction of antenatal betamethasone dosage.

Click to read the study in the Lancet

Relevant Reading: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth

In-Depth [randomized controlled trial]: BETADOSE was a double-blind, placebo-controlled, randomized control trial that enrolled pregnant women aged 18 years or older with a singleton fetus at risk of preterm delivery. Participants had already received an injective of betamethasone before 32 weeks gestation. Exclusion criteria included having received a full course of steroids, being cervically dilated greater than 4 cm, and having a multiple pregnancy. 3244 women were randomized 1:1 to either half-dose (n = 1620) or full-dose (n= 1624) betamethasone. The half-dose group received a placebo dose rather than a second dose of 11.4 mg betamethasone. The primary outcome was the need for intratracheal surfactant within 48 hours of birth. In the intention-to-treat analysis, the primary outcome was observed in 20% of the half-dose group compared to 17.5% of the full-dose group (risk difference 2.4%, 95% CI -0.3 to 5.2). Non-inferiority was defined prior as shown if the higher limit of the 95% CI was less than 4 percentage points. Thus, non-inferiority was not shown. There were no risk differences of neonatal death or severe adverse events (grade 3-4 intraventricular hemorrhage, stage >2 necrotizing enterocolitis, severe retinopathy of prematurity, or bronchopulmonary dysplasia) between the two groups.

RELATED REPORTS

Methylprednisolone after hip replacement surgery improves pain and sleep quality

Higher rate of adverse events following abortion induced by mifepristone-misoprostol than procedurally

2 Minute Medicine Rewind January 2, 2023

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: betamethasonecelestonecorticosteroidlaborneonatalneonatal mortalityneonatalogyobstetricspreterm birthpreterm deliverypreterm infantpreterm laborsurfactant
Previous Post

#VisualAbstract: Dapaglifozin reduced risk of worsening heart failure or cardiovascular death among patients with heart failure

Next Post

Transfemoral transcatheter aortic valve replacement vs surgical valve replacement outcomes at 5 years

RelatedReports

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Surgery

Methylprednisolone after hip replacement surgery improves pain and sleep quality

January 24, 2023
Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Emergency

Higher rate of adverse events following abortion induced by mifepristone-misoprostol than procedurally

January 10, 2023
Stochastic resonance stimulation may decrease apnea of prematurity
Weekly Rewinds

2 Minute Medicine Rewind January 2, 2023

January 3, 2023
Late gestation antidepressant use linked to postpartum hemorrhage
Obstetrics

Monofilament suture does not reduce pregnancy loss compared to braided suture for cervical cerclage

December 13, 2022
Next Post
Quick Take: Intravenous patient-controlled analgesia versus thoracic epidural analgesia after open liver surgery

Transfemoral transcatheter aortic valve replacement vs surgical valve replacement outcomes at 5 years

Parents often unaware of adolescents’ suicidal thoughts

Wellness check: Mental health

Traditional healers may improve health equity amongst Latine individuals in the United States

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Torsemide does not provide additional decrease in mortality compared to furosemide among patients hospitalized for heart failure
  • Community-based adult vision screening program increases access to eye care
  • Aspirin thromboprophylaxis noninferior to low-molecular-weight heparin in patients with fractures
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options